BIOMAT Database Logo BIOMAT Database Logo

A new method for extracting DNA or RNA for polymerase chain reaction. 1990

O Yamada, and T Matsumoto, and M Nakashima, and S Hagari, and T Kamahora, and H Ueyama, and Y Kishi, and H Uemura, and T Kurimura
Department of Virology, Tottori University School of Medicine, Yonago, Japan.

The use of glass powder suspension for the extraction of RNA or DNA was studied to simplify the procedures of polymerase chain reaction (PCR). Using this procedure, proviral DNA of human T-lymphotropic virus type-1 (HTLV-1) in the blood of an asymptomatic virus carrier and viral RNA of human immunodeficiency virus (HIV) in the blood of an AIDS patient were easily detected by PCR employing glass powder. The use of glass powder is a simple and highly efficient procedure for the extraction of DNA or RNA, and can be applied for routine PCR.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D011208 Powders Substances made up of an aggregation of small particles, as that obtained by grinding or trituration of a solid drug. In pharmacy it is a form in which substances are administered. (From Dorland, 28th ed) Powder
D011533 Proviruses Duplex DNA sequences in eukaryotic chromosomes, corresponding to the genome of a virus, that are transmitted from one cell generation to the next without causing lysis of the host. Proviruses are often associated with neoplastic cell transformation and are key features of retrovirus biology. Provirus
D004279 DNA, Viral Deoxyribonucleic acid that makes up the genetic material of viruses. Viral DNA
D005898 Glass Hard, amorphous, brittle, inorganic, usually transparent, polymerous silicate of basic oxides, usually potassium or sodium. It is used in the form of hard sheets, vessels, tubing, fibers, ceramics, beads, etc.
D006678 HIV Human immunodeficiency virus. A non-taxonomic and historical term referring to any of two species, specifically HIV-1 and/or HIV-2. Prior to 1986, this was called human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). From 1986-1990, it was an official species called HIV. Since 1991, HIV was no longer considered an official species name; the two species were designated HIV-1 and HIV-2. AIDS Virus,HTLV-III,Human Immunodeficiency Viruses,Human T-Cell Lymphotropic Virus Type III,Human T-Lymphotropic Virus Type III,LAV-HTLV-III,Lymphadenopathy-Associated Virus,Acquired Immune Deficiency Syndrome Virus,Acquired Immunodeficiency Syndrome Virus,Human Immunodeficiency Virus,Human T Cell Lymphotropic Virus Type III,Human T Lymphotropic Virus Type III,Human T-Cell Leukemia Virus Type III,Immunodeficiency Virus, Human,Immunodeficiency Viruses, Human,Virus, Human Immunodeficiency,Viruses, Human Immunodeficiency,AIDS Viruses,Human T Cell Leukemia Virus Type III,Lymphadenopathy Associated Virus,Lymphadenopathy-Associated Viruses,Virus, AIDS,Virus, Lymphadenopathy-Associated,Viruses, AIDS,Viruses, Lymphadenopathy-Associated
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000163 Acquired Immunodeficiency Syndrome An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993. AIDS,Immunodeficiency Syndrome, Acquired,Immunologic Deficiency Syndrome, Acquired,Acquired Immune Deficiency Syndrome,Acquired Immuno-Deficiency Syndrome,Acquired Immuno Deficiency Syndrome,Acquired Immuno-Deficiency Syndromes,Acquired Immunodeficiency Syndromes,Immuno-Deficiency Syndrome, Acquired,Immuno-Deficiency Syndromes, Acquired,Immunodeficiency Syndromes, Acquired,Syndrome, Acquired Immuno-Deficiency,Syndrome, Acquired Immunodeficiency,Syndromes, Acquired Immuno-Deficiency,Syndromes, Acquired Immunodeficiency
D001483 Base Sequence The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence. DNA Sequence,Nucleotide Sequence,RNA Sequence,DNA Sequences,Base Sequences,Nucleotide Sequences,RNA Sequences,Sequence, Base,Sequence, DNA,Sequence, Nucleotide,Sequence, RNA,Sequences, Base,Sequences, DNA,Sequences, Nucleotide,Sequences, RNA
D012367 RNA, Viral Ribonucleic acid that makes up the genetic material of viruses. Viral RNA

Related Publications

O Yamada, and T Matsumoto, and M Nakashima, and S Hagari, and T Kamahora, and H Ueyama, and Y Kishi, and H Uemura, and T Kurimura
[A new method for detection of DNA polymorphisms using the polymerase chain reaction].
December 1990, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme,
O Yamada, and T Matsumoto, and M Nakashima, and S Hagari, and T Kamahora, and H Ueyama, and Y Kishi, and H Uemura, and T Kurimura
Ribo-polymerase chain reaction--a facile method for the preparation of chimeric RNA/DNA applied to DNA sequencing.
June 2012, Human mutation,
O Yamada, and T Matsumoto, and M Nakashima, and S Hagari, and T Kamahora, and H Ueyama, and Y Kishi, and H Uemura, and T Kurimura
Polymerase chain reaction-a novel method for analyzing specific DNA sequences.
November 1988, The Western journal of medicine,
O Yamada, and T Matsumoto, and M Nakashima, and S Hagari, and T Kamahora, and H Ueyama, and Y Kishi, and H Uemura, and T Kurimura
Polymerase Chain Reaction for RNA Analysis
December 1996, Methods (San Diego, Calif.),
O Yamada, and T Matsumoto, and M Nakashima, and S Hagari, and T Kamahora, and H Ueyama, and Y Kishi, and H Uemura, and T Kurimura
Contaminating DNA in RNA amplification by polymerase chain reaction.
June 1992, Clinical chemistry,
O Yamada, and T Matsumoto, and M Nakashima, and S Hagari, and T Kamahora, and H Ueyama, and Y Kishi, and H Uemura, and T Kurimura
Tandem competitive polymerase chain reaction (TC-PCR): a method for determining ratios of RNA and DNA templates.
October 1992, Molecular and cellular probes,
O Yamada, and T Matsumoto, and M Nakashima, and S Hagari, and T Kamahora, and H Ueyama, and Y Kishi, and H Uemura, and T Kurimura
A new reverse transcription-polymerase chain reaction method for accurate quantification.
December 2003, BMC biotechnology,
O Yamada, and T Matsumoto, and M Nakashima, and S Hagari, and T Kamahora, and H Ueyama, and Y Kishi, and H Uemura, and T Kurimura
Triplex DNA: A new platform for polymerase chain reaction-based biosensor.
August 2015, Scientific reports,
O Yamada, and T Matsumoto, and M Nakashima, and S Hagari, and T Kamahora, and H Ueyama, and Y Kishi, and H Uemura, and T Kurimura
A rapid membrane-based viral RNA isolation method for the polymerase chain reaction.
July 1991, Nucleic acids research,
O Yamada, and T Matsumoto, and M Nakashima, and S Hagari, and T Kamahora, and H Ueyama, and Y Kishi, and H Uemura, and T Kurimura
New method for the extraction of viral RNA and DNA from cerebrospinal fluid for use in the polymerase chain reaction assay.
May 1995, Journal of virological methods,
Copied contents to your clipboard!